Home | Sitemap | Search | ContactA- A A+
   
 
    Public Member Support us  
 
Home > Public > Health Professionals / Clinical Trials

Clinical Trials 

The IBCSG pioneers research in combined hormonal therapy and chemotherapy, timing and duration of adjuvant therapies and quality of life of breast cancer patients. The latest generation of trials in the adjuvant setting addresses tailored treatment for subgroups of patients, as we also expand our research into neoadjuvant treatment and chemotherapy for advanced disease. In addition to clinical trials, we conduct extensive programs in translational research, database studies, quality of life and statistical methodology. IBCSG strives to conduct clinical trials at the highest level of knowledge in breast cancer medicine, trial methodology, data handling, and ethical conduct.

The IBCSG is a cooperative international group with demonstrated success conducting collaborative clinical trials. The IBCSG has coordinated 36 clinical trials since 1977, 4 of them currently enrolling patients. The IBCSG clinical database of closed trials is available for subgroup analyses or analyses pooling data from several trials to evaluate specific hypotheses. More than 35,500 patients have participated in IBCSG-coordinated clinical trials as of April 2018.

News

23.03.2019:
The next IBCSG Annual Meeting will take place in Vienna Austria on March 23 and 24, 2019.       

20.03.2019:
16th St. Gallen International Breast Cancer Conference Primary Therapy of Early Breast Cancer

09.10.2018:
Clinical Trials

All News


 
  Print